Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,446.43%-222.36K | 15.80%-128.58K | -38.94%-236.3K | 95.68%-11.15K | -201.25%-58.06K | -137.76%-14.38K | -321.17%-152.71K | 58.01%-170.07K | -127.48%-257.93K | 89.79%-19.27K |
| Net income from continuing operations | 378.96%339.52K | 37.07%-63.94K | -85.54%-1.45M | -183.72%-1.11M | 16.42%-113.75K | 8.89%-121.71K | 14.56%-101.59K | -6.90%-779.67K | -98.53%-391.08K | 49.98%-136.09K |
| Operating gains losses | --9.47K | --3.52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | ---- | 347.94%661.84K | ---- | ---- | ---- | ---- | --147.75K | ---- | ---- |
| Unrealized gains and losses of investment securities | --2.95K | ---35.45K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | --13K | --0 | --0 | --0 | --0 | --0 | --0 | --12.2K | --0 | --0 |
| Other non cashItems | ---- | ---- | 344.59%108.13K | --120K | ---- | ---- | ---- | 53.85%-44.21K | --0 | -195.33%-43.38K |
| Change In working capital | -154.98%-59.01K | 35.99%-32.72K | -10.83%440.35K | 2,268.80%316.58K | -57.83%67.56K | -37.48%107.33K | -128.95%-51.12K | 64.17%493.85K | -110.25%-14.6K | 469.89%160.19K |
| -Change in receivables | -95.17%3.03K | 102.77%1.62K | -100.76%-316 | -44.24%27.35K | -201.23%-32.05K | 141.26%62.76K | -137.64%-58.38K | -41.95%41.42K | 975.60%49.05K | -114.41%-10.64K |
| -Change in payables and accrued expense | -239.20%-62.04K | -572.66%-34.33K | -2.60%440.67K | 554.42%289.23K | -41.69%99.6K | -86.23%44.57K | -66.20%7.26K | 97.16%452.43K | -143.02%-63.65K | 245.86%170.83K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,446.43%-222.36K | 15.80%-128.58K | -38.94%-236.3K | 95.68%-11.15K | -201.25%-58.06K | -137.76%-14.38K | -321.17%-152.71K | 58.01%-170.07K | -127.48%-257.93K | 89.79%-19.27K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 130.19K | 479.95%15.2K | 30.92%-30.83K | 39.02%-24.97K | 49.48%-1.86K | 0 | -4K | 81.01%-44.62K | -165.60%-40.95K | 95.22%-3.68K |
| Net PPE purchase and sale | ---8.1K | -113.30%-8.53K | 30.92%-30.83K | 39.02%-24.97K | 49.48%-1.86K | --0 | ---4K | 85.65%-44.62K | -44.11%-40.95K | 97.37%-3.68K |
| Net investment purchase and sale | --138.28K | --23.73K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --130.19K | 479.95%15.2K | 30.92%-30.83K | 39.02%-24.97K | 49.48%-1.86K | --0 | ---4K | 81.01%-44.62K | -165.60%-40.95K | 95.22%-3.68K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 22.48%413.13K | -102.70%-6.94K | -48.65%337.29K | 2,868.92%257.51K | ||||||
| Net common stock issuance | ---- | ---- | 17.06%456.5K | --0 | ---- | ---- | ---- | -52.91%389.98K | --282.35K | ---- |
| Net other financing activities | ---- | ---- | 17.68%-43.37K | 72.05%-6.94K | ---- | ---- | ---- | 69.26%-52.68K | -167.10%-24.84K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | 22.48%413.13K | -102.70%-6.94K | ---- | ---- | ---- | -48.65%337.29K | 2,868.92%257.51K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 582.84%221.81K | 77.17%335.2K | 184.08%189.19K | 64.06%378.26K | -89.58%18.11K | -76.05%32.48K | 184.08%189.19K | 33.85%66.6K | 12.63%230.56K | 45.72%173.73K |
| Current changes in cash | -541.04%-92.18K | 27.65%-113.39K | 19.10%146.01K | -4.10%-43.06K | 533.72%360.16K | -137.76%-14.38K | -326.96%-156.71K | 627.96%122.6K | 70.05%-41.37K | -33.52%56.83K |
| End cash Position | 616.04%129.64K | 582.84%221.81K | 77.17%335.2K | 77.17%335.2K | 64.06%378.26K | -89.58%18.11K | -76.05%32.48K | 184.08%189.19K | 184.08%189.19K | 12.63%230.56K |
| Free cash from | -1,502.73%-230.46K | 12.50%-137.12K | -24.42%-267.12K | 87.92%-36.12K | -161.08%-59.92K | -137.76%-14.38K | -326.96%-156.71K | 73.69%-214.7K | -110.78%-298.88K | 94.65%-22.95K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.